Related Experiment Video

Updated: May 20, 2026

A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury
11:17

A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury

Published on: November 28, 2025

An Asian validation of the TIMI risk score for ST-segment elevation myocardial infarction

Sharmini Selvarajah1, Alan Yean Yip Fong, Gunavathy Selvaraj

  • 1Clinical Epidemiology Unit, Clinical Research Centre, Kuala Lumpur Hospital, Kuala Lumpur, Malaysia. s.selvarajah@umcutrecht.nl

Plos One
|July 21, 2012
PubMed

Insights

The Thrombolysis In Myocardial Infarction (TIMI) risk score effectively stratifies risk for ST-elevation myocardial infarction (STEMI) patients in developing nations. This validated score aids in targeted treatment for better clinical outcomes.

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • Risk stratification is crucial for optimizing ST-elevation myocardial infarction (STEMI) treatment, especially in resource-limited developing countries.
  • Cardiovascular diseases pose a growing burden in these regions, necessitating validated risk assessment tools.
  • The study addresses the need to validate the Thrombolysis In Myocardial Infarction (TIMI) risk score in a multi-ethnic developing country context.

Purpose of the Study:

  • To validate the Thrombolysis In Myocardial Infarction (TIMI) risk score for ST-elevation myocardial infarction (STEMI) patients.
  • To assess the score's applicability in a developing country with diverse healthcare facilities and a high burden of cardiovascular disease.
  • To evaluate the score's performance in specific high-risk subgroups, including diabetics and patients with renal impairment.

Main Methods:

  • Utilized data from a national, prospective, observational registry of acute coronary syndromes.
  • Evaluated the TIMI risk score in 4701 patients presenting with STEMI.
  • Assessed model discrimination (c-statistic) and calibration (goodness-of-fit tests) in the overall population and high-risk subgroups.

Main Results:

  • The study population differed from the original TIMI cohort, being younger with more comorbidities and later treatment.
  • The TIMI risk score demonstrated strong association with 30-day mortality.
  • Good discrimination was observed for the overall population (c-statistic 0.785) and high-risk subgroups (diabetics: 0.764, renal impairment: 0.761).
  • Calibration was good for the overall population and diabetics but poor for those with renal impairment.

Conclusions:

  • The Thrombolysis In Myocardial Infarction (TIMI) risk score is a valid tool for risk stratification in ST-elevation myocardial infarction (STEMI) patients.
  • The score can guide targeted treatment strategies to improve clinical benefits in developing countries.
  • Further refinement may be needed for optimal use in patients with renal impairment.
Abstract

More Related Videos

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...